1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Recalls

Q3 Recalls Snapshot: Recalled Devices Slide In Third Quarter; Software A Nagging Issue

 
• By Shawn M. Schmitt

Good news for the medical device industry: After two record-setting quarters, the number of recalled products and device units fell in the third quarter of 2018. Yet device-makers are still having problems with software, which was the leading cause of recalls in Q3. Check out our Q3 recalls infographic.

Q3 Results

Good news for the medical device industry: After two record-setting quarters, the number of recalled products fell to 284 in the third quarter of 2018 from a high of 360 recorded in Q2. That marks a decrease of 76 events, or 21%, from the prior quarter, consulting firm Stericycle said in its most recent recalls index. The 284 recalls initiated in Q3 is also 17% lower than Q1's 343 events, according to Stericycle, which tracks device recalls by gathering data from FDA Enforcement Reports. Also down in the third quarter was the number of recalled device units, which dropped to 29.4 million from Q2's 42.2 million – a decrease of 31%. And for the 10th quarter in a row, device-makers blamed software issues as the top cause of recalls, trailed by mislabeling and quality.

From the editors of The Gray Sheet

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Recalls

Philips S&RC CEO Leonard Talks Respironics Recall Lessons

 
• By Ashley Yeo

The recall of various Respironics sleep and respiratory care devices in 2021 plunged Philips into static growth and market share loss. Careful remediation is the group’s top priority, but S&RC head Dan Leonard is determined that the manner of its achievement will be the envy of the industry.

After Success Of Early Alert Pilot, FDA Builds Out Program To Include All Devices

 
• By Brian Bossetta

The US FDA’s device center says the pilot program launched last year to streamline its recall process has been a success. It’s now starting to build off the program’s achievements, which means patients could be aware of potential safety issues from more types of devices.

J&J’s Abiomed Issues Third Recall Of Automated Impella Controllers Since June

 
• By Brian Bossetta

The US FDA has issued a safety alert regarding an Abiomed recall of Automated Impella Controllers, the primary interface for pumps that help to reduce demand on heart’s left ventricle in heart failure patients.

Blood Sugar Spike Risk Leads To Recall Of Tandem Insulin Pumps

 
• By Brian Bossetta

Tandem Diabetes Care initiated a recall last month of several t:slim X2 insulin pumps due to a “malfunction 16” error that can cause the pumps to shut down. The problem is triggered by wiring within the device speaker.

More from Policy & Regulation

German Medtechs Choking Under EU Compliance And Reporting Obligations Tout Mutual Recognition

 
• By Ashley Yeo

Industry survey points to ongoing low revenues rise and weaker profit levels for half of BVMed industry association members in 2025, as German manufacturers raise stakes on global harmonization.

Fixing The Fractures: New Aspirations For EU Medtech Regulatory Progress

 
• By Amanda Maxwell

A pioneering initiative, Edvance MedTech, is being launched by leading experts in medical technology regulation which aims get to the heart of what is needed to improve the way EU rules are not only applied but also decided.

MedTech Innovator Winner Armor Medical Hopes To Reduce 90% Of Preventable Maternal Deaths

 
• By Marion Webb

Armor Medical’s wrist-worn wearable detected postpartum hemorrhage five times earlier than standard care in earlier studies. After surviving near-fatal hemorrhage herself, co-founder/CEO Kelsey Mayo aims to bring the device to market in 2028.